Effectiveness and Cost-Effectiveness of Sequential Treatment of Patients with Chronic Myeloid Leukemia in the United States: A Decision Analysis

Currently several tyrosine kinase inhibitors (TKIs) are approved for treatment of chronic myeloid leukemia (CML). Our goal was to identify the optimal sequential treatment strategy in terms of effectiveness and cost-effectiveness for CML patients within the US health care context. We evaluated 18 tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rochau, Ursula, Kluibenschaedl, Martina, Stenehjem, David, Kuan-Ling, Kuo, Radich, Jerald, Oderda, Gary, Brixner, Diana, Siebert, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689963/
https://www.ncbi.nlm.nih.gov/pubmed/26783469
http://dx.doi.org/10.1155/2015/982395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689963/
https://www.ncbi.nlm.nih.gov/pubmed/26783469
http://dx.doi.org/10.1155/2015/982395

Ejemplares similares